<div id="readability-page-1"><div> <div> , /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited (&#34;Charming &#34; or &#34;the Company&#34;) (NASDAQ: MCTA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MCTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: October 21, 2025 to November 12, 2025 DEADLINE: February 17, 2026 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. The SEC suspended the trading of Charming shares based on the investigation of an alleged scheme to boost the Company's share price by supposed financial advisors touting shares on social media. Based on these facts, Charming's public statements were false and materially misleading throughout the class period. If you are a shareholder who suffered a loss, contact us to participate. WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&amp;A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results. Join the case to recover your losses. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: David J. Schwartz DJS Law Group 274 White Plains Road, Suite 1 Eastchester, NY 10709 Phone: 914-206-9742 Email: [email protected] SOURCE DJS Law Group LLP <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA5Jk5ld3NJdGVtSWQ9TEE4MzIwNCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDkxNjAxUFJfTkVXU19VU1BSX19fX19MQTgzMjA0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMjA5Jk5ld3NJdGVtSWQ9TEE4MzIwNCZUcmFuc21pc3Npb25fSWQ9MjAyNjAyMDkxNjAxUFJfTkVXU19VU1BSX19fX19MQTgzMjA0"/></div> </div></div>

MCTA

Charming Medical Limited (NASDAQ: MCTA) is facing a class action lawsuit for securities law violations, specifically for making false and misleading statements, as per the DJS Law Group. The lawsuit pertains to the period from October 21, 2025, to November 12, 2025, with a deadline for lead plaintiff appointments set for February 17, 2026. The SEC has suspended trading of Charming shares due to an investigation into alleged schemes to artificially inflate share prices. Shareholders who incurred losses are encouraged to participate in the lawsuit.

prnewswire

Charming Medical

iShares Global Healthcare

16:01 ETCharming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA